UK health services wants more from MDA (Medical Devices Agency) as it moves closer to users
This article was originally published in Clinica
The launch last month of the UK Medical Devices Agency's new facility for electronic adverse incident reporting marked the beginning of a new era of drawing in medical professionals, patients and members of the public who use devices directly into the feedback loop of reporting on medical devices.
You may also be interested in...
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.